Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 6 | 2023 | 83 | 3.240 |
Why?
|
| Osteoporosis | 4 | 2022 | 16 | 2.520 |
Why?
|
| Familial Hypophosphatemic Rickets | 3 | 2023 | 3 | 2.290 |
Why?
|
| Bone Density | 12 | 2023 | 49 | 2.140 |
Why?
|
| Animals | 25 | 2023 | 760 | 1.970 |
Why?
|
| Bone and Bones | 8 | 2023 | 47 | 1.810 |
Why?
|
| Female | 15 | 2023 | 1048 | 1.650 |
Why?
|
| Biomarkers | 7 | 2022 | 57 | 1.640 |
Why?
|
| Humans | 21 | 2023 | 2066 | 1.450 |
Why?
|
| Male | 18 | 2023 | 1130 | 1.320 |
Why?
|
| Osteolysis | 4 | 2019 | 14 | 1.220 |
Why?
|
| Bone Remodeling | 4 | 2021 | 29 | 1.210 |
Why?
|
| Osteocalcin | 5 | 2022 | 10 | 1.180 |
Why?
|
| Calcium, Dietary | 2 | 2018 | 5 | 1.170 |
Why?
|
| Implants, Experimental | 3 | 2021 | 11 | 1.070 |
Why?
|
| Bone Matrix | 2 | 2017 | 9 | 1.010 |
Why?
|
| X-Ray Microtomography | 8 | 2023 | 38 | 0.990 |
Why?
|
| Anti-HIV Agents | 2 | 2023 | 10 | 0.970 |
Why?
|
| Mice | 9 | 2023 | 219 | 0.960 |
Why?
|
| Fractures, Bone | 2 | 2022 | 12 | 0.890 |
Why?
|
| Osseointegration | 3 | 2021 | 23 | 0.890 |
Why?
|
| Tooth | 1 | 2023 | 1 | 0.880 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2023 | 3 | 0.840 |
Why?
|
| Bone Development | 1 | 2023 | 16 | 0.820 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 81 | 0.800 |
Why?
|
| Lactation | 2 | 2018 | 4 | 0.760 |
Why?
|
| HIV Seropositivity | 1 | 2021 | 17 | 0.730 |
Why?
|
| Bone-Implant Interface | 1 | 2020 | 3 | 0.710 |
Why?
|
| Prosthesis Retention | 1 | 2020 | 3 | 0.710 |
Why?
|
| Joint Prosthesis | 1 | 2020 | 4 | 0.710 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2021 | 95 | 0.670 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2018 | 12 | 0.650 |
Why?
|
| Rats | 10 | 2021 | 160 | 0.650 |
Why?
|
| Bone Regeneration | 5 | 2021 | 33 | 0.640 |
Why?
|
| Parathyroid Hormone | 2 | 2021 | 6 | 0.640 |
Why?
|
| Titanium | 2 | 2021 | 31 | 0.630 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 3 | 0.620 |
Why?
|
| Weaning | 1 | 2018 | 2 | 0.620 |
Why?
|
| Minerals | 1 | 2018 | 4 | 0.620 |
Why?
|
| Glycoproteins | 2 | 2018 | 13 | 0.610 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2018 | 11 | 0.600 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 54 | 0.590 |
Why?
|
| Phosphates | 3 | 2021 | 6 | 0.510 |
Why?
|
| Osteogenesis | 3 | 2021 | 35 | 0.480 |
Why?
|
| Antibodies | 1 | 2014 | 11 | 0.460 |
Why?
|
| Osteoporotic Fractures | 1 | 2014 | 3 | 0.450 |
Why?
|
| Calcitonin | 1 | 2014 | 4 | 0.450 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 4 | 0.450 |
Why?
|
| Fracture Fixation | 1 | 2014 | 4 | 0.450 |
Why?
|
| Diphosphonates | 1 | 2014 | 5 | 0.450 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 28 | 0.440 |
Why?
|
| Absorptiometry, Photon | 3 | 2023 | 11 | 0.430 |
Why?
|
| Graft vs Host Disease | 2 | 2022 | 2 | 0.390 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2022 | 5 | 0.390 |
Why?
|
| Fibroblast Growth Factors | 2 | 2021 | 2 | 0.360 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 2 | 2021 | 2 | 0.360 |
Why?
|
| Wnt Signaling Pathway | 2 | 2021 | 6 | 0.340 |
Why?
|
| Bone Diseases, Metabolic | 2 | 2023 | 6 | 0.330 |
Why?
|
| Femur | 4 | 2021 | 66 | 0.310 |
Why?
|
| Middle Aged | 2 | 2021 | 544 | 0.290 |
Why?
|
| Prosthesis Failure | 2 | 2020 | 18 | 0.290 |
Why?
|
| Aged | 2 | 2018 | 461 | 0.270 |
Why?
|
| Polyethyleneimine | 3 | 2015 | 6 | 0.270 |
Why?
|
| Calcium | 2 | 2018 | 191 | 0.260 |
Why?
|
| Adult | 3 | 2022 | 602 | 0.240 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 67 | 0.240 |
Why?
|
| Skull | 2 | 2015 | 7 | 0.240 |
Why?
|
| Tissue Scaffolds | 2 | 2014 | 7 | 0.230 |
Why?
|
| Periodontal Ligament | 1 | 2023 | 1 | 0.220 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2021 | 7 | 0.220 |
Why?
|
| Prostheses and Implants | 2 | 2014 | 37 | 0.220 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 97 | 0.220 |
Why?
|
| Biomechanical Phenomena | 2 | 2020 | 53 | 0.220 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2023 | 2 | 0.210 |
Why?
|
| Mice, Transgenic | 1 | 2023 | 27 | 0.210 |
Why?
|
| Osteocytes | 2 | 2019 | 5 | 0.210 |
Why?
|
| HIV-1 | 1 | 2023 | 51 | 0.200 |
Why?
|
| Anti-Retroviral Agents | 1 | 2022 | 4 | 0.200 |
Why?
|
| Cartilage | 1 | 2022 | 13 | 0.200 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 111 | 0.200 |
Why?
|
| Cognition | 1 | 2022 | 75 | 0.190 |
Why?
|
| Hypogonadism | 1 | 2021 | 1 | 0.190 |
Why?
|
| Infertility | 1 | 2021 | 2 | 0.190 |
Why?
|
| Testicular Neoplasms | 1 | 2021 | 6 | 0.190 |
Why?
|
| Emtricitabine | 1 | 2021 | 1 | 0.190 |
Why?
|
| Femur Neck | 1 | 2021 | 3 | 0.190 |
Why?
|
| Rats, Zucker | 1 | 2021 | 2 | 0.190 |
Why?
|
| Ovariectomy | 1 | 2021 | 6 | 0.190 |
Why?
|
| Collagen Type I | 1 | 2021 | 4 | 0.180 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2021 | 11 | 0.180 |
Why?
|
| Viral Load | 1 | 2021 | 11 | 0.180 |
Why?
|
| Adipose Tissue | 1 | 2021 | 6 | 0.180 |
Why?
|
| Azepines | 1 | 2021 | 1 | 0.180 |
Why?
|
| Chondrosarcoma | 1 | 2021 | 1 | 0.180 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2021 | 1 | 0.180 |
Why?
|
| Triazoles | 1 | 2021 | 3 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2021 | 6 | 0.180 |
Why?
|
| Transcription Factors | 1 | 2021 | 35 | 0.180 |
Why?
|
| Bone Neoplasms | 1 | 2021 | 11 | 0.180 |
Why?
|
| Plasmids | 3 | 2015 | 10 | 0.180 |
Why?
|
| Arthroplasty, Replacement | 1 | 2020 | 3 | 0.180 |
Why?
|
| Body Weight | 1 | 2019 | 15 | 0.170 |
Why?
|
| Independent Living | 1 | 2018 | 12 | 0.160 |
Why?
|
| Porosity | 1 | 2018 | 14 | 0.160 |
Why?
|
| Memory, Short-Term | 1 | 2018 | 14 | 0.160 |
Why?
|
| Comorbidity | 1 | 2018 | 29 | 0.160 |
Why?
|
| Prognosis | 1 | 2018 | 30 | 0.160 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 13 | 0.150 |
Why?
|
| Prevalence | 1 | 2018 | 28 | 0.150 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 38 | 0.150 |
Why?
|
| Double-Blind Method | 1 | 2018 | 37 | 0.150 |
Why?
|
| Pregnancy | 1 | 2018 | 38 | 0.150 |
Why?
|
| Risk Assessment | 1 | 2018 | 37 | 0.150 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 63 | 0.150 |
Why?
|
| Syndactyly | 1 | 2018 | 1 | 0.150 |
Why?
|
| Hyperostosis | 1 | 2018 | 1 | 0.150 |
Why?
|
| Anabolic Agents | 1 | 2018 | 2 | 0.150 |
Why?
|
| Radiography | 1 | 2018 | 35 | 0.150 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 230 | 0.150 |
Why?
|
| Gene Transfer Techniques | 2 | 2015 | 10 | 0.140 |
Why?
|
| Cortical Bone | 1 | 2017 | 6 | 0.140 |
Why?
|
| RNA | 1 | 2015 | 3 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2015 | 10 | 0.130 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2015 | 6 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 10 | 0.120 |
Why?
|
| Chitosan | 1 | 2014 | 2 | 0.120 |
Why?
|
| Copper | 1 | 2014 | 6 | 0.120 |
Why?
|
| Microvessels | 1 | 2014 | 3 | 0.120 |
Why?
|
| Corpus Striatum | 1 | 2014 | 10 | 0.120 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2014 | 5 | 0.120 |
Why?
|
| Methamphetamine | 1 | 2014 | 5 | 0.120 |
Why?
|
| Fracture Healing | 1 | 2014 | 9 | 0.120 |
Why?
|
| Diaphyses | 1 | 2014 | 3 | 0.120 |
Why?
|
| Macaca fascicularis | 1 | 2014 | 3 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2014 | 4 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 15 | 0.120 |
Why?
|
| Models, Animal | 1 | 2014 | 24 | 0.110 |
Why?
|
| Thiophenes | 1 | 2014 | 3 | 0.110 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2014 | 4 | 0.110 |
Why?
|
| Humerus | 1 | 2014 | 10 | 0.110 |
Why?
|
| Bone Resorption | 1 | 2014 | 15 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 20 | 0.110 |
Why?
|
| Tibia | 1 | 2014 | 23 | 0.110 |
Why?
|
| Lumbar Vertebrae | 1 | 2014 | 27 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 69 | 0.110 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2013 | 2 | 0.110 |
Why?
|
| Bone Marrow | 2 | 2022 | 22 | 0.100 |
Why?
|
| Quality of Life | 2 | 2022 | 31 | 0.100 |
Why?
|
| DNA | 3 | 2015 | 24 | 0.090 |
Why?
|
| Rats, Inbred F344 | 3 | 2015 | 7 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 14 | 0.080 |
Why?
|
| Calcification, Physiologic | 2 | 2019 | 10 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2021 | 20 | 0.070 |
Why?
|
| Cell Survival | 2 | 2015 | 13 | 0.060 |
Why?
|
| Genetic Therapy | 2 | 2015 | 18 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 78 | 0.050 |
Why?
|
| Lamivudine | 1 | 2023 | 3 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 9 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 6 | 0.050 |
Why?
|
| Transplant Recipients | 1 | 2022 | 4 | 0.050 |
Why?
|
| Disease Progression | 1 | 2022 | 48 | 0.050 |
Why?
|
| Immunoassay | 1 | 2021 | 3 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2021 | 3 | 0.050 |
Why?
|
| Cellular Senescence | 1 | 2021 | 3 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 4 | 0.050 |
Why?
|
| Proteins | 1 | 2021 | 6 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 3 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 18 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 6 | 0.040 |
Why?
|
| Polyethylene | 1 | 2019 | 4 | 0.040 |
Why?
|
| Surface Properties | 1 | 2019 | 17 | 0.040 |
Why?
|
| Motor Activity | 1 | 2019 | 21 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 1 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2018 | 6 | 0.040 |
Why?
|
| Spine | 1 | 2018 | 3 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2018 | 12 | 0.040 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2018 | 8 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 8 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2018 | 133 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2017 | 17 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 8 | 0.030 |
Why?
|
| Craniocerebral Trauma | 1 | 2015 | 4 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2015 | 11 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2015 | 18 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 37 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 2 | 0.030 |
Why?
|
| Hypoxia | 1 | 2014 | 3 | 0.030 |
Why?
|
| Receptors, Endothelin | 1 | 2014 | 3 | 0.030 |
Why?
|
| Self Administration | 1 | 2014 | 4 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 2014 | 3 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2014 | 5 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2014 | 10 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2013 | 11 | 0.030 |
Why?
|
| Transfection | 1 | 2013 | 19 | 0.030 |
Why?
|
| Collagen | 1 | 2013 | 21 | 0.030 |
Why?
|
| Gene Expression | 1 | 2013 | 27 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 25 | 0.030 |
Why?
|